UnknownNot Applicable

Effect of Behavioral Intervention on Interdialytic Weight Gain in Patients Undergoing Hemodialysis

Pakistan130 participantsStarted 2021-04-30

Plain-language summary

A randomized clinical trial will be conducted in which effect of behavioral intervention (Text message of dietary salt and fluid restriction) on inter-dialytic weight gain in hemodialysis patients. The purpose of this is to evaluate the efficacy of a technology supported intervention for reducing inter-dialytic weight gain and dietary sodium intake in patients undergoing intermittent hemodialysis.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients above 18 years of age * Patients with End stage renal disease and on maintenance hemodialysis at least twice a week for at least 1 month * Patients or immediate family members have access to mobile phones * Patients are able to read and understand text message in urdu language Exclusion Criteria: * Patients with terminal illness and limited life expectancy of less than 1 month * Patients with Dementia * Patients with visual impairment * Patients with Acute Kidney injury requiring hemodialysis

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Mean inter-dialytic weight gain

Timeframe: 8 weeks

Trial details

NCT IDNCT04892225

SponsorFarooq Hospital - West Wood Branch

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-01

Contact for this trial

Salman Tahir Shafi, MBBS

+92 306 4000 715 salmanshafi@email.com

View on ClinicalTrials.gov More End Stage Renal Disease trials